• Admin

Five Covid deaths reported in two days


By Pacific Island Times News Staff


Guam reported five Covid-19 related deaths in two days, raising the island's death toll to 349.


The 347th fatality occurred at Guam Regional Medical City on March 15. The patient was a 78-year-old male, unvaccinated, who had underlying health conditions and tested positive on March 7.


The 348th fatality occurred at GRMC on March 18. The patient was a 63-year-old female, fully vaccinated with a booster, who had underlying health conditions and tested positive on Feb. 16.


The 349th fatality occurred at St. Dominic’s on March 22. The patient was a 96-year-old female, fully vaccinated without a booster, who had underlying health conditions and tested positive on March 13.


Two Covid deaths were reported on Thursday night.


The 345th fatality was a 41-year-old man who passed away at GRMC on March 25. The patient was unvaccinated, who had underlying health conditions and tested positive on March 19.


The 346th fatality occurred at Guam Memorial Hospital on March 30. The patient was a 70-year-old male, fully vaccinated, who had underlying health conditions and tested positive on March 19


The Department of Public Health and Social Services reported 46 new cases of Covid-19 from 747 specimens analyzed on March 31, 2022. 21 of the cases reported today are through the Department of Defense. To date, there have been a total of 47,311 officially reported cases, 349 deaths, 813 cases in active isolation, and 46,149 not in active isolation.


ADVERTISEMENT


Today, DPHSS issued a standing order for the second booster dose of either the Pfizer-BioNTech or Moderna Covid-19 vaccines for individuals 50 years of age or older and for certain immunocompromised individuals following completion of a three-dose primary vaccination series. The standing order provides guidance as follows:


People ages 12 years and older who are moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose


Adults ages 50 years and older who are not moderately or severely immunocompromised may choose to receive a second booster dose using an mRNA COVID-19 vaccine at least 4 months after the first booster dose.


People ages 18-49 years who are not moderately or severely immunocompromised and who received Janssen Covid-19 Vaccine as both their primary series dose and booster dose may receive a second booster dose using an mRNA Covid-19 vaccine at least 4 months after the first Janssen booster dose.


Further clarification of safety issues including those related to multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A) and myocarditis



Subscribe to

our digital

monthly edition